NOW APPROVED
in Adults with
PRURIGO NODULARIS (PN)
DUPIXENT is
a prescription medicine
used to treat adults with
prurigo nodularis (PN). It
is not known if
DUPIXENT is safe and
effective in children with
prurigo nodularis under
18 years of age.
DUPIXENT can help control
a source of unwanted
inflammation which could
be a driver of your PN
Proven results*
~3x as many adults had
significantly less itch at
24 weeks
(In trial 1, 60% on DUPIXENT vs 18.4% on placebo; in trial 2,
57.7% on DUPIXENT vs 19.5% on placebo)
Some adults had less itch
in as little as 12 weeks
(In trial 2, 37.2% on DUPIXENT vs 22% on placebo)
~3x as many adults had
skin that's clear or
almost clear of PN
bumps at 24 weeks
(In trial 1, 48% on DUPIXENT vs 18.4% on placebo; in trial 2,
44.9% on DUPIXENT vs 15.9% on placebo)
The most common side
effects in patients with
prurigo nodularis include eye
and eyelid inflammation,
including redness, swelling,
and itching, sometimes with
blurred vision, herpes virus
infections, common cold
symptoms (nasopharyngitis),
dizziness, muscle pain,
and diarrhea.
NOW FDA APPROVED